The FDA Is Stepping Back From Medical AI. California Is Stepping In.
Forbes
Read the full article
The FDA is reducing its regulatory oversight of clinical AI technologies, prompting California and other states to develop their own regulations. This shift could lead to a patchwork of state-level rules governing medical AI applications.
